Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors (SEED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02015728
Recruitment Status : Unknown
Verified December 2016 by Sarah Leary, Seattle Children's Hospital.
Recruitment status was:  Active, not recruiting
First Posted : December 19, 2013
Last Update Posted : December 15, 2016
Cures Within Reach
Information provided by (Responsible Party):
Sarah Leary, Seattle Children's Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : November 2016
  Estimated Study Completion Date : December 2017